Connect with us

Hi, what are you looking for?


Biogen stock pumps 48% amid upgrade. What to watch out for

Biogen Inc. (NASDAQ:BIIB) gained more than 48% on Wednesday’s stock premarket. The stock was among the top trends on popular social trading platforms. There were definite reasons.

On Tuesday, company news indicated that Biogen and Japanese Eisai had achieved success in Alzheimer’s drug trials. The disease candidate, lecanemab, slowed cognitive decline by 27% in parties under observation for over 18 months. The results indicated a potential breakthrough in addressing the disease menace, Alzheimer. Analysts took note. 

On September 28. BMO Capital upgraded Biogen to “outperform” from “market perform. The analysts also increased the price target from $217 to $360. The stock was trading at $197 as of press time. The analysts said the positive report was an “unequivocal win for AD patients and Biogen.”

BMO reiterated a $13.3 billion or £12.55 billion unadjusted lecanemab peak sales. That was an increase from the previous $5.4 billion or £5.09 billion. Similarly, Mizuho analysts assigned a buy rating from neutral, with a price target of $270 from $207. 

Biogen is contained by the $280 resistance

With the positive sentiment on Biogen and ratings, Biogen could maintain sentiment. Eyes will turn to key levels as momentum increases.

Source – TradingView

A breakout above $220 makes a bullish case for Biogen. However, the double-digit intraday gains make Biogen unattractive at the current level. The stock has also met resistance at $280. Investors should consider buying lower.

Alternatively, Biogen could break above the $280 barrier if momentum remains strong. The level could attract buyers and should be closely watched.

When to buy Biogen

Buy Biogen on a retracement towards the $220 support. The alternative is to buy on a breakout at $280. The next resistance is around $370.

The post Biogen stock pumps 48% amid upgrade. What to watch out for appeared first on Invezz.

Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.

    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like


    Solana (SOL/USD) is enormously underrated as a cryptocurrency project, even with its hiccups – including the latest exploit on one of the ecosystem apps....

    Editor's Pick

    The new eSIM infrastructure will help modernise the IoT connectivity market with fast, secure connections and reduced vendor lock-in. 1oT, a tech startup from...


    The latest Job Openings and Labor Turnover Survey from the Bureau of Labor Statistics shows the total number of job openings in the economy...


    U.S. District Court Judge Reed O’Connor recently ruled to uphold the rights of employers granted in the Religious Freedom Restoration Act, rather than uphold...

    Disclaimer:, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2023